The Strüngmann Family Office, managed by Thomas and Andreas Strüngmann, is a prominent single family office known for its significant investments in the healthcare and biotechnology sectors. The family office is particularly noted for its early backing of BioNTech, a company that gained global recognition for its COVID-19 vaccine developed in partnership with Pfizer. The Strüngmann brothers manage their substantial fortune through their family office, Athos, which oversees their investments and assets.
Focus Areas
Notable Investments
